MCMCB Pro
J0642

J0642Injection, levoleucovorin (khapzory), 0.5 mg

HCPCSActiveBETOS O1E

J0642 is a HCPCS Level II code for injection, levoleucovorin (khapzory), 0.5 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J0642 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
1200 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
1200 units
MAI 3 — Date of Service Edit: Clinical · Prescribing Information

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J0642

Long descriptor
Injection, levoleucovorin (khapzory), 0.5 mg

The official wording. This is what the code means.

Short descriptor
Injection, khapzory, 0.5 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
October 1, 2019

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J0642

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0642 is not quite right, the correct code is very often within a few positions of it.

  • J0618Injection, calcium chloride, 2 mg
  • J0620Injection, calcium glycerophosphate and calcium lactate, per 10 ml
  • J0630Injection, calcitonin salmon, up to 400 units
  • J0636Injection, calcitriol, 0.1 mcg
  • J0637Injection, caspofungin acetate, 5 mg
  • J0638Injection, canakinumab, 1 mg
  • J0640Injection, leucovorin calcium, per 50 mg
  • J0641Injection, levoleucovorin, not otherwise specified, 0.5 mg
  • J0650Injection, levothyroxine sodium, not otherwise specified, 10 mcg
  • J0651Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg
  • J0652Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg
  • J0654Injection, liothyronine, 1 mcg
  • J0665Injection, bupivicaine, not otherwise specified, 0.5 mg
  • J0666Injection, bupivacaine liposome, 1 mg
  • J0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg
  • J0670Injection, mepivacaine hydrochloride, per 10 ml

Questions about J0642

What is HCPCS code J0642?

J0642 is a HCPCS Level II code for injection, levoleucovorin (khapzory), 0.5 mg. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J0642?

The CMS HCPCS file marks J0642 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is J0642 paid under the physician fee schedule?

J0642 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026